These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2540516)

  • 1. Rapid elevation of liver hydroxyproline content following a single administration of various chemical carcinogens to rats.
    Watanabe A; Yamauchi Y; Kobayashi M; Nagashima H
    Res Exp Med (Berl); 1989; 189(1):43-6. PubMed ID: 2540516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose responses of five hepatocarcinogens for the initiation of rat hepatocarcinogenesis.
    Imaida K; Shirai T; Tatematsu M; Takano T; Ito N
    Cancer Lett; 1981 Dec; 14(3):279-83. PubMed ID: 6800641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme deviation patterns in primary rat hepatomas induced by sequential administration of two chemically different carcinogens.
    Sato K; Hatayama I; Hoshino K; Imai F; Tsuchida S; Sato T; Nishimura K; Tatematsu M; Ito N
    Cancer Res; 1981 Oct; 41(10):4147-53. PubMed ID: 6269736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of carbon tetrachloride and azathioprine on diethylnitrosamine and N-2-fluorenylacetamide-induced hyperplastic liver nodule and hepatocellular carcinoma.
    Sakata T
    Acta Med Okayama; 1984 Dec; 38(6):511-24. PubMed ID: 6524446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of azathioprine and carbon tetrachloride on induction of hyperplastic liver nodule and hepatocellular carcinoma by diethylnitrosamine and N-2-fluorenylacetamide in rats.
    Sakata T; Watanabe A; Takei N; Shiota T; Nakatsukasa H; Fujiwara M; Kobayashi M; Nagashima H
    Ann N Y Acad Sci; 1983; 417():288-93. PubMed ID: 6142675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remarkable difference in the incidence of liver tumors by N-nitrosodimethylamine in carcinogen-resistant DRH rat and its parental strain Donryu rat.
    Yan Y; Higashi K; Tanimoto A; Fukamachi Y; Itoh H; Abe T; Higashi T
    J UOEH; 1998 Dec; 20(4):307-14. PubMed ID: 9883481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the promoting effects of various agents in induction of preneoplastic lesions in rat liver.
    Ito N; Tsuda H; Hasegawa R; Imaida K
    Environ Health Perspect; 1983 Apr; 50():131-8. PubMed ID: 6191977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinction between liver neoplasm promoting and syncarcinogenic effects demonstrated by exposure to phenobarbital or diethylnitrosamine either before or after N-2-fluorenylacetamide.
    Williams GM; Furuya K
    Carcinogenesis; 1984 Feb; 5(2):171-4. PubMed ID: 6697434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of albumin-positive cells in the liver of analbuminemic rats and their increase on treatment with hepatocarcinogens.
    Makino R; Sato S; Esumi H; Negishi C; Takano M; Sugimura T; Nagase S; Tanaka H
    Jpn J Cancer Res; 1986 Feb; 77(2):153-9. PubMed ID: 3082826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormalities in liver iron accumulation during N-2-fluorenylacetamide hepatocarcinogenesis that are dependent or independent of continued carcinogen action.
    Furuya K; Maeura Y; Williams GM
    Toxicol Pathol; 1984; 12(2):136-42. PubMed ID: 11478314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of timing of partial hepatectomy on the induction of preneoplastic liver foci in rats given hepatocarcinogens.
    Hasegawa R; Tsuda H; Shirai T; Kurata Y; Masuda A; Ito N
    Cancer Lett; 1986 Jul; 32(1):15-23. PubMed ID: 2427192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different responses other than the formation of DNA-adducts between the livers of carcinogen-resistant rats (DRH) and carcinogen-sensitive rats (Donryu) to 3'-methyl-4-dimethylaminoazobenzene administration.
    Yan Y; Higashi K; Yamamura K; Fukamachi Y; Abe T; Gotoh S; Sugiura T; Hirano T; Higashi T; Ichiba M
    Jpn J Cancer Res; 1998 Aug; 89(8):806-13. PubMed ID: 9765615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aryl sulfotransferase IV deficiency in rat liver carcinogenesis initiated with diethylnitrosamine and promoted with N-2-fluorenylacetamide or its C-9-oxidized metabolites.
    Malejka-Giganti D; Ringer DP; Vijayaraghavan P; Kiehlbauch CC; Kong J
    Exp Mol Pathol; 1997 Apr; 64(2):63-77. PubMed ID: 9316585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of bioelectric potential in primary hepatocellular carcinomas induced by N-2-fluorenylacetamide or diethylnitrosamine.
    Lai CN; Becker FF
    Cancer Biochem Biophys; 1982; 6(1):1-6. PubMed ID: 7093932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different responses to phenobarbital promotion in the development of gamma-glutamyltranspeptidase-positive foci in the liver of rats initiated with diethylnitrosamine, N-hydroxy-2-acetyl-aminofluorene and aflatoxin B1.
    Shirai T; Imaida K; Ohshima M; Fukushima S; Lee MS; King CM; Ito N
    Jpn J Cancer Res; 1985 Jan; 76(1):16-9. PubMed ID: 2857671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of rapid initiating, promoting or sequential syncarcinogenic effects of di(2-ethylhexyl)phthalate in rat liver carcinogenesis.
    Williams GM; Maruyama H; Tanaka T
    Carcinogenesis; 1987 Jul; 8(7):875-80. PubMed ID: 3594721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of hyperplastic liver nodules in hepatectomized rats treated with 3'-methyl-4-dimethylaminoazobenzene, benzo[a]pyrene or phenobarbital before or after exposure to N-2-fluorenylacetamide.
    Hasegawa R; Tatematsu M; Tsuda H; Shirai T; Hagiwara A; Ito N
    Gan; 1982 Apr; 73(2):264-9. PubMed ID: 6288500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of selected hepatotoxic agents on polyribosomes and protein synthesis in the livers of rats fed purified diets containing hepatocarcinogens.
    Sidransky H; Verney E
    Exp Mol Pathol; 1982 Feb; 36(1):72-85. PubMed ID: 7056372
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of neoplastic development in rat liver, kidney, oesophagus and forestomach by 4,4'-diaminodiphenylmethane administration.
    Tsuda H; Ogiso T; Hasegawa R; Imaida K; Masui T; Ito N
    Carcinogenesis; 1987 May; 8(5):719-22. PubMed ID: 3581430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target polypeptide of a carcinogen is associated with normal mitosis and carcinogen-induced hyperplasias in adult hepatocytes.
    Custer RP; Sorof S
    Proc Natl Acad Sci U S A; 1984 Nov; 81(21):6738-42. PubMed ID: 6593726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.